Vicore Pharma (Sweden) Probability of Future Stock Price Finishing Over 34.51
| VICO Stock | SEK 7.84 0.36 4.39% |
Vicore |
Vicore Pharma Target Price Odds to finish over 34.51
The tendency of Vicore Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over kr 34.51 or more in 90 days |
| 7.84 | 90 days | 34.51 | close to zero percent |
Based on a normal probability distribution, the odds of Vicore Pharma to move over kr 34.51 or more in 90 days from now is close to zero percent (This Vicore Pharma Holding probability density function shows the probability of Vicore Stock to fall within a particular range of prices over 90 days) . Probability of Vicore Pharma Holding price to stay between its current price of kr 7.84 and kr 34.51 at the end of the 90-day period is about 63.46 .
Assuming the 90 days trading horizon Vicore Pharma Holding has a beta of -1.72. This entails as returns on its benchmark rise, returns on holding Vicore Pharma Holding are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Vicore Pharma is expected to outperform its benchmark. Additionally Vicore Pharma Holding has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Vicore Pharma Price Density |
| Price |
Predictive Modules for Vicore Pharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Vicore Pharma Holding. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Vicore Pharma Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Vicore Pharma is not an exception. The market had few large corrections towards the Vicore Pharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Vicore Pharma Holding, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Vicore Pharma within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.59 | |
β | Beta against Dow Jones | -1.72 | |
σ | Overall volatility | 2.50 | |
Ir | Information ratio | -0.14 |
Vicore Pharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Vicore Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Vicore Pharma Holding can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Vicore Pharma generated a negative expected return over the last 90 days | |
| Vicore Pharma has high historical volatility and very poor performance | |
| Vicore Pharma has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (296.48 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Vicore Pharma Holding has accumulated about 215.97 M in cash with (265.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.1. | |
| Roughly 16.0% of the company outstanding shares are owned by insiders |
Vicore Pharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Vicore Stock often depends not only on the future outlook of the current and potential Vicore Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Vicore Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 69.7 M | |
| Cash And Short Term Investments | 371.2 M |
Vicore Pharma Technical Analysis
Vicore Pharma's future price can be derived by breaking down and analyzing its technical indicators over time. Vicore Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Vicore Pharma Holding. In general, you should focus on analyzing Vicore Stock price patterns and their correlations with different microeconomic environments and drivers.
Vicore Pharma Predictive Forecast Models
Vicore Pharma's time-series forecasting models is one of many Vicore Pharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Vicore Pharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Vicore Pharma Holding
Checking the ongoing alerts about Vicore Pharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Vicore Pharma Holding help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Vicore Pharma generated a negative expected return over the last 90 days | |
| Vicore Pharma has high historical volatility and very poor performance | |
| Vicore Pharma has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (296.48 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Vicore Pharma Holding has accumulated about 215.97 M in cash with (265.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.1. | |
| Roughly 16.0% of the company outstanding shares are owned by insiders |
Additional Tools for Vicore Stock Analysis
When running Vicore Pharma's price analysis, check to measure Vicore Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vicore Pharma is operating at the current time. Most of Vicore Pharma's value examination focuses on studying past and present price action to predict the probability of Vicore Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vicore Pharma's price. Additionally, you may evaluate how the addition of Vicore Pharma to your portfolios can decrease your overall portfolio volatility.